Abstract:Background Most previous assessments of the hazardous effects attributable to fine particulate matter (PM2.5) exposure have used ambient PM2.5 as an exposure metric, resulting in substantial bias in effect estimates. We did a study to examine the association between cause-specific mortality and the time-weighted average of PM2.5 exposure after accounting for indoor exposure in 267 cities in China. Methods We did a nationwide study, using Laser Egg air quality monitors in 36 cities to obtain data for indoor PM2.5 concentrations from 18 484 anonymised households between Nov 1, 2015 and July 2, 2018. We developed and validated a nationwide indoor PM2.5 prediction model for a further 302 cities by retrieving raw records of hourly concentrations from residents' air sensors; the model was used to predict indoor PM2.5 during 2013 to 2018. Daily ambient PM2.5 concentration data were estimated by averaging hourly ambient PM2.5 concentrations obtained from China's National Urban Air Quality Real-time Publishing Platform. Daily numbers of deaths from all non-accidental causes were obtained from 324 cities from the Disease Surveillance Point System of China between Jan 1, 2013, to Dec 31, 2017, and calculated for 267 cities that had an average daily mortality above three, and data for PM2.5 concentrations and meteorological information for at least 1 year between 2013 and 2017. We used distributed lag non-linear models to estimate city-specific associations between cause-specific mortality and reconstructed PM2.5 exposure by considering indoor PM2.5 exposure. We combined the city-specific effect estimates at the national level using a random effects meta-analysis. Findings 13 972 records of daily indoor PM2.5 concentrations for 36 cities, extracted from 47 459 183 raw records from the sensors were included for modelling indoor PM2.5 levels. The nationwide indoor PM2.5 concentration was 40 mu g/m(3) (SD 21) between 2013 and 2017, which was approximately 20% lower than the ambient PM2. 5 concentration of 50 mu g/m(3) (42). An increase of 10 mu g/m(3) in time-averaged PM2.5 exposure concentrations was associated with increased daily mortality estimates of 0.44% (95% CI 0.33-0.54) for total non-accidental causes, 0.50% (0 .37-0 63) for cardiovascular diseases, 0.46% (0 28-0 .63) for coronary heart disease, 0.49% (0.32-0.66) for stroke, 0.59% (0 .39-0 79) for respiratory diseases, and 0.69% (0 .45-0. 92) for chronic obstructive pulmonary disease, respectively. Compared with previous estimations based on ambient PM(2.5 )our estimates approximately doubled the size of the effects related to PM2.5. Interpretation This nationwide study revealed a higher mortality risk attributed to time-averaged indoor and ambient PM2.5 exposure compared with the risk associated with ambient PM2.5 exposure alone, which indicates that caution should be exercised when using ambient PM2.5 as a surrogate for PM2.5 exposure. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd.

Substantial health benefits of strengthening guidelines on indoor fine particulate matter in China

An Assessment of the Potential Health Benefits of Realizing the Goals for PM 10 in the Updated Chinese Ambient Air Quality Standard

Tightening Standards for Indoor Levels of PM2.5: A Promising Approach for Reducing PM2.5 Associated Mortalities in Urban China

Reducing Indoor Levels of "outdoor PM2.5" in Urban China: Impact on Mortalities

Impacts of Implementing Healthy Building Guidelines for Daily PM2.5 Limit on Premature Deaths and Economic Losses in Urban China: A Population-Based Modeling Study.

Deaths Attributable to Indoor PM2.5 in Urban China when Outdoor Air Meets 2021 WHO Air Quality Guidelines

Mortality Effects Assessment of Ambient PM2.5 Pollution in the 74 Leading Cities of China.

Mortality Burden Attributable to PM1 in Zhejiang Province, China.

Long-Term Exposure to PM2.5 and Mortality: A Cohort Study in China

Potential Reductions in Premature Mortality Attributable to PM2.5 by Reducing Indoor Pollution: A Model Analysis for Beijing-Tianjin-Hebei of China.

Increasing Mortality Caused by Chronic Obstructive Pulmonary Disease (COPD) in Relation with Exposure to Ambient Fine Particulate Matters: an Analysis in Southeastern China

Specific differences and responses to reductions for premature mortality attributable to ambient PM2.5 in China

Estimating the mortality attributable to indoor exposure to particulate matter of outdoor origin in mainland China

Reduction of Human Exposure and Premature Deaths by Indoor PM<Subscript>2.5</Subscript> Cleaning in Beijing, China

Indoor PM2.5 Mortality in China when Outdoor Air Meets 2021 WHO AQG

Time-weighted Average of Fine Particulate Matter Exposure and Cause-Specific Mortality in China: a Nationwide Analysis.

Air pollution control and carbon reduction policies: Assessing effectiveness in alleviating PM 2.5 -associated mortality in China

Estimating Adult Mortality Attributable to PM2.5 Exposure in China with Assimilated PM2.5 Concentrations Based on a Ground Monitoring Network

Premature mortality attributable to PM2.5 pollution in China during 2008–2016: Underlying causes and responses to emission reductions

Estimation of the PM2.5 Health Effects in China During 2000–2011

Health benefits and cost of using air purifiers to reduce exposure to ambient fine particulate pollution in China